Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-19-001254
Filing Date
2019-01-15
Accepted
2019-01-15 21:15:33
Documents
1
Period of Report
2019-01-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 16544
  Complete submission text file 0000899243-19-001254.txt   17912
Mailing Address 11682 EL CAMINO REAL, SUITE 320 SAN DIEGO CA 92130
Business Address
Reisman Neil (Reporting) CIK: 0001465834 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35921 | Film No.: 19528017

Mailing Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Issuer) CIK: 0001576263 (see all company filings)

EIN.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations